Roger Waters: Antisemitism is odious, and I condemn it
Statement by Roger Waters on antisemitism, his criticism of the Israeli government and freedom of speech
London. Statement by Mr George Roger Waters dated 16.03.2023:
“My lawyers are taking steps to ensure that my concerts in Munich and Frankfurt in May 2023 take place as contracted. Human rights and freedom of speech for all peoples under German law must prevail, which is why I’m taking this stance to ensure the will of the few will not prevent me from performing in Frankfurt and Munich.
I am taking the unprecedented step of appealing to the law to protect me from the unconstitutional actions of two authorities which seem to rely upon the fundamentally false accusation that has been made against me; namely that I am antisemitic.
I want to state for the record and once and for all that I am not and never have been antisemitic and nothing that anyone can say or publish will alter that. My well-publicized views relate entirely to the policies and actions of the Israeli government and not with the peoples of Israel. Antisemitism is odious and racist, and I condemn it, along with all forms of racism unreservedly.
I am not going to and do not need to keep making my position clear on this issue. I am confident that truth and the law will prevail and that these authorities will not succeed in denying any of my basic human rights.”
Publisher:
Mark Fenwick Management – London
on behalf of Mr George Roger Waters
Press Contact:
HÖCKER Rechtsanwälte PartGmbB
Rechtsanwalt Prof. Dr. Ralf Höcker
Rechtsanwalt Michael Fengler
Friesenplatz 1
50672 Köln
Germany
E-Mail: contact@hoecker.eu
Tel: +49(0)221-93319-10
Fax: +49(0)221-93319-110
Följ news aktuell GmbH
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från news aktuell GmbH
New management for the EUTOP Group22.4.2024 10:24:58 CEST | Pressmeddelande
Stefan Mappus is the new Managing Director of the EUTOP Group. Together with long-standing Managing Director Christian Schaufler, he will manage the fortunes of the Group from now on. Stefan Mappus is responsible for EUTOP's client business as a member of the management board and thus brings his wealth of experience in politics, administration and business directly to the benefit of EUTOP's clients.
Additional partnership in medical technology: Bosch and R-Biopharm to strengthen Vivalytic analysis platform18.4.2024 10:15:00 CEST | Press release
Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria
Elatec Brings Employee Badge for Apple Wallet to Users17.4.2024 08:30:00 CEST | Press release
Munich, April 17, 2024 – Elatec today announced it is bringing employee badge in Apple Wallet to its customers, enabling an organization’s employees or tenants to unlock access to locations and devices with a simple tap of their iPhone or Apple Watch. Powered by Elatec’s Mobile Credential Manager software, which works hand-in-hand with Elatec’s universal RFID readers, this brings together the world’s most powerful and versatile readers with the best mobile access system available. Employee badge in Apple Wallet helps deliver a convenient and contactless experience for users. Once enabled, employee badge in Apple Wallet allows users to seamlessly and securely add their employee badge to Apple Wallet, and hold their iPhone or Apple Watch near an NFC reader to unlock office doors, turnstiles, elevators and key card-protected amenity spaces — eliminating the need to open an app or present a traditional, plastic access key. With Express Mode, employees do not need to unlock their device to
Severe Vulnerabilities Discovered in Software to Protect Internet Routing11.4.2024 16:51:22 CEST | Pressmeddelande
A research team from the National Research Center for Applied Cybersecurity ATHENE led by Prof. Dr. Haya Schulmann has uncovered 18 vulnerabilities in crucial software components of Resource Public Key Infrastructure (RPKI). RPKI is an Internet standard meant to protect Internet traffic from being hijacked by hackers. By now, all affected vendors provided patches for their products. The vulnerabilities could have had devastating consequences: Internet hijacks have already been exploited, e.g., for phishing passwords and other sensitive information, tricking certificate authorities into issuing fraudulent Web certificates, stealing cryptocurrency, distributing malware, and poisoning caches of DNS servers.
Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment10.4.2024 11:00:00 CEST | Press release
The launch in Germany through its step-down subsidiary betapharm marks Dr. Reddy's entry into digital therapeutics in Europe. Nerivio® is the first REN (wearable, FDA-cleared, and CE-marked for acute and/or prevention migraine (with or without aura) treatment for adults and adolescents (≥ 12 years). Nerivio® is worn on the upper arm during treatment and controlled by a smartphone app, making it comfortable and portable. Starting with Germany, followed by Spain and the UK, Dr. Reddy's plans to further increase access to Nerivio® in European countries.
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.
Besök vårt pressrum